These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 28787742

  • 41. Effectiveness of allergic rhinitis treatments in real-life with a focus on MP-AzeFlu.
    Klimek L, Demoly P, Price D.
    Expert Rev Clin Pharmacol; 2016; 9(5):705-14. PubMed ID: 26839083
    [Abstract] [Full Text] [Related]

  • 42. Azelastine desensitization of transient receptor potential vanilloid 1: a potential mechanism explaining its therapeutic effect in nonallergic rhinitis.
    Singh U, Bernstein JA, Haar L, Luther K, Jones WK.
    Am J Rhinol Allergy; 2014; 28(3):215-24. PubMed ID: 24980233
    [Abstract] [Full Text] [Related]

  • 43. Long-term, randomized safety study of MP29-02 (a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate in an advanced delivery system) in subjects with chronic rhinitis.
    Berger WE, Shah S, Lieberman P, Hadley J, Price D, Munzel U, Bhatia S.
    J Allergy Clin Immunol Pract; 2014; 2(2):179-85. PubMed ID: 24607046
    [Abstract] [Full Text] [Related]

  • 44. Postnasal drip and chronic cough: An open interventional study.
    Macedo P, Saleh H, Torrego A, Arbery J, MacKay I, Durham SR, Chung KF.
    Respir Med; 2009 Nov; 103(11):1700-5. PubMed ID: 19481918
    [Abstract] [Full Text] [Related]

  • 45. [Nasal irrigation for the treatment of vasomotor rhinitis: a pilot study].
    Lin L, Lu Q, Tang XY, Dai F, Wei JJ.
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jun 07; 52(6):446-452. PubMed ID: 28635218
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Meta-analysis of azelastine nasal spray for the treatment of allergic rhinitis.
    Lee TA, Pickard AS.
    Pharmacotherapy; 2007 Jun 07; 27(6):852-9. PubMed ID: 17542768
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Fluticasone propionate aqueous nasal spray reduces inflammatory cells in unchallenged allergic nasal mucosa: effects of single allergen challenge.
    Holm A, Dijkstra M, Kleinjan A, Severijnen LA, Boks S, Mulder P, Fokkens W.
    J Allergy Clin Immunol; 2001 Apr 07; 107(4):627-33. PubMed ID: 11295650
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Intranasal fluticasone propionate inhibits recovery of chemokines and other cytokines in nasal secretions in allergen-induced rhinitis.
    Weido AJ, Reece LM, Alam R, Cook CK, Sim TC.
    Ann Allergy Asthma Immunol; 1996 Nov 07; 77(5):407-15. PubMed ID: 8933780
    [Abstract] [Full Text] [Related]

  • 57. Alteration of brain activation patterns in nonallergic rhinitis patients using functional magnetic resonance imaging before and after treatment with intranasal azelastine.
    Bernstein JA, Hastings L, Boespflug EL, Allendorfer JB, Lamy M, Eliassen JC.
    Ann Allergy Asthma Immunol; 2011 Jun 07; 106(6):527-32. PubMed ID: 21624753
    [Abstract] [Full Text] [Related]

  • 58. Effect of topical nasal azelastine on the symptoms of rhinitis, sleep, and daytime somnolence in perennial allergic rhinitis.
    Golden S, Teets SJ, Lehman EB, Mauger EA, Chinchilli V, Berlin JM, Kakumanu S, Lucus T, Craig TJ.
    Ann Allergy Asthma Immunol; 2000 Jul 07; 85(1):53-7. PubMed ID: 10923605
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Topical azelastine has a 12-hour duration of action as assessed by histamine challenge-induced exudation of alpha 2-macroglobulin into human nasal airways.
    Greiff L, Andersson M, Svensson C, Persson CG.
    Clin Exp Allergy; 1997 Apr 07; 27(4):438-44. PubMed ID: 9146938
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.